Trial intelligence / Profile preview

Bystolic vs Metoprolol in Type 2 Diabetics with Hypertension

NCT00829296Phase 3Completed

Sponsor
University of Chicago
Start
Jan 2009
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nebivolol in hypertension (HTN), sponsored by University of Chicago. Started Jan 2009; status: completed.

02

Drugs

nebivolol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00829296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00829296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call